You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 65 No. 7, July 2008 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Pediatrics
 •Adolescent Psychiatry
 •Public Health
 •Substance Abuse/ Alcoholism
 •Genetics
 •Genetic Disorders
 •Alert me on articles by topic

Systematic Analysis of Glutamatergic Neurotransmission Genes in Alcohol Dependence and Adolescent Risky Drinking Behavior

Gunter Schumann, MD; Monika Johann, MD; Josef Frank, MA; Ulrich Preuss, MD; Norbert Dahmen, MD; Manfred Laucht, PhD; Marcella Rietschel, MD; Dan Rujescu, MD; Anbarasu Lourdusamy, PhD; Toni-Kim Clarke, MRes; Kristina Krause, MA; Anne Dyer, PhD; Martin Depner, MA; Stefan Wellek, PhD; Jens Treutlein, PhD; Armin Szegedi, MD; Ina Giegling, PhD; Sven Cichon, PhD; Dorothea Blomeyer, MA; Andreas Heinz, MD; Simon Heath, PhD; Mark Lathrop, PhD; Norbert Wodarz, MD; Michael Soyka, MD; Rainer Spanagel, PhD; Karl Mann, MD

Arch Gen Psychiatry. 2008;65(7):826-838.

Context  Glutamatergic neurotransmission is implicated in alcohol-drinking behavior in animal models.

Objective  To investigate whether genetic variations in glutamatergic neurotransmission genes, which are known to alter alcohol effects in rodents, contribute to the genetic basis of alcoholism in humans.

Design  Association analysis of alcohol dependence and haplotype-tagging single nucleotide polymorphisms (SNPs) covering 10 glutamatergic genes. Resequencing of functional domains of these genes identified 204 SNPs. Haplotypes with a frequency of 5% or greater could be discriminated by 21 haplotype-tagging SNPs analyzed for association in 2 independent samples of alcohol-dependent adult patients and controls as well as adolescent trios.

Setting  Four university medical centers in the south of Germany.

Participants  One thousand three hundred thirty-seven patients and 1555 controls (study 1: 544 patients, 553 controls; study 2: 793 patients, 1002 controls). One hundred forty-four trios of 15-year-old adolescents assessed for risky drinking behavior.

Main Outcome Measures  Genotype profiles for GLAST; N-methyl-D-aspartate–receptor subunits NR1, NR2A, and NR2B; MGLUR5; NNOS; PRKG2; CAMK4; the regulatory subunit of PI3K; and CREB were analyzed for association with alcohol dependence using multivariate statistical analysis. Risky adolescent drinking was tested using the transmission disequilibrium test.

Results  Analysis of study 1 revealed that NR2A and MGLUR5 have the greatest relevance for human alcohol dependence among the genes selected with odds ratios of 2.35 and 1.69, respectively. Replication analysis in study 2 confirmed an association of alcohol dependence with NR2A (odds ratio, 2.01) but showed no association with MGLUR5. Combined analysis of study 1 and study 2 exhibited a more significant association on the Cochran-Mantel-Haenszel test (P < .001) for NR2A; NR2A was associated with positive family history, early onset of alcoholism, and maximum number of drinks in adults as well as risky drinking patterns in adolescents.

Conclusion  Genetic variations in NR2A have the greatest relevance for human alcohol dependence among the glutamatergic genes selected for their known alteration of alcohol effects in animal models.


Author Affiliations: Central Institute of Mental Health, Mannheim, Germany (Drs Schumann, Laucht, Rietschel, Dyer, Wellek, Treutlein, Spanagel, and Mann, Mssrs Frank and Depner, and Ms Blomeyer); MRC, SGDP Center & Division of Psychological Medicine, Institute of Psychiatry at King's College, London, England (Drs Schumann and Lourdusamy and Mss Clarke and Krause); Department of Psychiatry and Psychotherapy, University of Regensburg Bezirksklinikum, Regensburg, Germany (Drs Johann and Wodarz); Department of Psychiatry and Psychotherapy, Martin-Luther-University, Halle, Germany (Dr Preuss); Department of Psychiatry and Psychotherapy, University of Mainz, Mainz, Germany (Dr Dahmen); Department of Psychology, University of Potsdam, Potsdam, Germany (Dr Laucht); Department of Psychiatry and Psychotherapy, University of Munich, Munich, Germany (Drs Rujescu, Giegling, and Soyka); Global Clinical Development, Organon, Roseland, New Jersey (Dr Szegedi); Department of Genomics, Life and Brain Centre, University of Bonn, Bonn, Germany (Dr Cichon); Department of Psychiatry and Psychotherapy; Charité-Universitätsmedizin, Berlin, Germany (Dr Heinz); and Centre National de Génotypage, Evry, France (Drs Heath and Lathrop).


RELATED ARTICLE

This Month in Archives of General Psychiatry
Arch Gen Psychiatry. 2008;65(7):743.
FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.